Müller - Die lila Logistik SE

  • WKN: 621468
  • ISIN: DE0006214687
  • Land: Deutschland

Nachricht vom 04.03.2021 | 15:13

Müller - Die lila Logistik AG with a strong second half 2020

DGAP-News: Müller - Die lila Logistik SE / Key word(s): Preliminary Results
04.03.2021 / 15:13
The issuer is solely responsible for the content of this announcement.

Press Release
4th March 2021

Preliminary Figures for 2020
Müller - Die lila Logistik AG with a strong second half 2020

Besigheim, 4th March 2021.

MÜLLER | DIE LILA LOGISTIK achieved a solid result in the 2020 year, despite the impact of the Covid-19 pandemic. According to preliminary figures, the group's sales in the 2020 financial year were around €133 million (previous year: €138.8 million). With an operating profit (EBIT) of around €3.8 million, a solid result was achieved for 2020. Considering the production shutdowns of individual customers in the second quarter of 2020, business development was extremely satisfactory from management's point of view, especially in the second half of the year. The preliminary figures are subject to final changes in the context of the currently ongoing annual audit. The annual report for 2020 will be published on March 31, 2021 as planned.

Company Profile

MÜLLER | DIE LILA LOGISTIK is one of the leading logistics service providers that combines consulting and implementation for logistics solutions. Breaking through the classic separation of consulting and implementation takes place in the business units of Lila Consult and Lila Operating. MÜLLER | DIE LILA LOGISTIK develops integrated, customized logistics solutions in almost all industries. Around 1,500 employees work at 20 operating locations. The shares of Müller - Die lila Logistik AG are listed in the General Standard of the Frankfurt Stock Exchange.

Your contact for further information:

Müller - Die lila Logistik SE
Oliver Streich
Head of Corporate Communications,
Marketing & Investor Relations

Tel.: +49 (0) 7143 810 - 125

Reprint free of charge. Please send us an exemplar copy.


04.03.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie


Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021